Therapeutic Effect of Tacrosolv in Patients With Allergic Rhinoconjunctivitis

Clinical trial NCT04532710 · COMPLETED

Trial details

NCT number: NCT04532710
Sponsor: Marinomed Biotech AG
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Allergic Conjunctivitis Allergic Rhinitis

Start date: 2020-08-04
Primary completion: 2021-05-27
Enrollment: 64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.